Lactobacillus Mixture Hy7601+Ky1032

China Lactobacillus Mixture Hy7601+Ky1032, Find details about China Lactobacillus from Lactobacillus Mixture Hy7601+Ky1032

Min. Order: 1 kg
Port: Shanghai, China
Payment Terms: T/T
 

 

 
Lactobacillus Mixture Hy7601+Ky1032
Lactobacillus Mixture Hy7601+Ky1032

 

 
Lactobacillus Mixture Hy7601+Ky1032
Benefits
- Lose body fat, improve gut health
The mechanism of the action of Lactobacillus mixture HY7601 + KY1032 is clarified to help reduce body fat by modulating genes associated with metabolism and inflammation in the liver and adipose tissue. Also, the effects on human body are proved by a clinical trial. The study showed significant reduction in body fat, fat percentage, fat mass, fat area.

Chracteristics
  • Stability - 2.0 x 1011 CFU/g (18months at 10ºC ± 0.5ºC) 
  • FDA NDI certified - Lactobacillus plantarum KY1032
  • Isolated from plant (kimchi)
  • Functional Probiotics certified by MFDS (KFDA, Ministry of Food and Drug Safety)
       The certified probiotics for fat loss (Claim: may help reduce body fat)
  • 10 Research Publication
       (7) Improvement in obesity, (3) Neutral fat
  • Clinical Trial
      - Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduced body adiposity and Lp-PLA2 activity in overweight subjects.
 
 
Lactobacillus Mixture Hy7601+Ky1032
Clinical Trial
 
Description
In a study published in Journal of Functional Foods, compared to placebo, consumption of Lactobacillus HY7601+KY1032 (total 10B CFU, 1:1 ratio) showed the reduction of body weight, body fat percentage, and body fat mass and L1 subcutaneous fat area in overweight subjects. The 12 weeks clinical trial was conducted in Yonsei University Hospital, the major clinical center in South Korea.
A total of 95 (46 placebo group, average weight 73.5 ± 1.28 kg; 49 probiotic group, average weight 73.5 ± 1.42 kg) of volunteers who were included in the study completed it.

Results
After 12-week probiotic treatment, the probiotic group presented reductions in body weight (−0.65 ± 0.23kg), body fat percentage (−0.57 ± 0.19%) and body fat mass (−616 ±161g) compared to baseline without affecting lean body mass.